Two Sigma Securities, LLC Vista Gen Therapeutics, Inc. Transaction History

Two Sigma Securities, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	SELL	$0.12 - $0.3 $1,434 - $3,586	-11,956 Reduced 25.5%	34,939 $4,000
Q4 2022 Feb 14, 2023	SELL	$0.09 - $4.8 $1,008 - $53,764	-11,201 Reduced 19.28%	46,895 $4,000
Q3 2022 Nov 14, 2022	BUY	$0.14 - $4.8 $8,133 - $278,860	58,096 New	58,096 $9,000
Q2 2021 Aug 16, 2021	SELL	$1.96 - $3.15 $25,278 - $40,625	-12,897 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$1.89 - $2.96 $24,375 - $38,175	12,897 New	12,897 $27,000
Q1 2020 May 15, 2020	SELL	$0.32 - $0.8 $23,435 - $58,589	-73,237 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$0.3 - $1.41 $21,971 - $103,264	73,237 New	73,237 $51,000

2.7M

Ticker VTGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 206,836,000
Market Cap $610M
Description
VistaGen Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in developing and commercializing various medicines with the potential to care for anxiety, depression, and other disorders of the central nervous system (CNS). The company's CNS pipeline includes PH94B, a rapid-onset neuroactive nasal spray, which is in Phase III d...

Get notified when there are updates to the investment portfolio of Two Sigma Securities, LLC, based on Form 13F filings with the SEC.

Stay updated on Two Sigma Securities, LLC with notifications on news.